Surrozen develops antibody-based therapies that target the Wnt pathway, with a focus on eye diseases. It last closed at $28.46 on Nov 20, down 7.21% on the day. The next earnings report for SRZN is expected around Mon, Mar 22, 2027, after the close. For the quarter ended Sep 2026, SRZN reported EPS of -$11.02 on revenue of $0, with revenue down 100.0% from a year ago. Over its last 8 reports the stock moved an average of 5.8% the session after earnings. Over the last 12 months SRZN insiders bought $8.9M of stock on the open market and sold $7.2M, according to SEC Form 4 filings.
AI Auto Pilots
Is SRZN in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold SRZN.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on SRZNStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
SRZN · as of the Nov 20 close · updated each morning
Uptrend
The stock sits between its 20 and 50 day averages. It is 9% above its 200 day average, so the longer trend is still up. Momentum is fading (RSI 47). The nearest support is the Pivot S1 at $27.69, and the nearest resistance the Pivot at $29.02.
Short trendBullish
Long trendBullish
MomentumFading
StretchNormal
VolatilityNormal, 8.7%/day
Key levels
$37.8352 week high+32.9%
$30.97Swing high (Oct 9)+8.8%
$30.4720 day average+7.1%
$29.79Pivot R1+4.7%
$29.02Pivot+2.0%
$28.46Last close
$27.69Pivot S1−2.7%
$26.9350 day average−5.4%
$25.84200 day average−9.2%
$24.69100 day average−13.2%
$22.84Swing low (Aug 14)−19.7%
$12.7952 week low−55.1%
Indicators
RSI (14)
47.18
Middle of its range
Neutral
MACD
1.04
Below its signal line
Bearish
Stochastic
39.1
Middle of its range
Neutral
ADX (14)
30.7
Trending up
Williams %R
-96.2
Oversold below −80, overbought above −20
Oversold
CCI (20)
-78.8
Oversold below −100, overbought above 100
Neutral
Rate of change
−8.2%
Change over 10 sessions
Bearish
ATR (14)
$2.47
Typical daily range, 8.7% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
Uptrend
Short trendBullish
Long trendBullish
MomentumImproving
StretchNormal
VolatilityNormal, 18.3%/day
Key levels
$37.8352 week high+32.9%
$30.97Swing high (Oct 9)+8.8%
$30.4720 day average+7.1%
$29.79Pivot R1+4.7%
$29.02Pivot+2.0%
$28.46Last close
$27.69Pivot S1−2.7%
$26.9350 day average−5.4%
$25.84200 day average−9.2%
$24.69100 day average−13.2%
$22.84Swing low (Aug 14)−19.7%
$12.7952 week low−55.1%
Indicators
RSI (14)
54.22
Middle of its range
Neutral
MACD
1.54
Above its signal line
Bullish
Stochastic
65.5
Middle of its range
Neutral
ADX (14)
19.9
No clear trend
Williams %R
-43.2
Oversold below −80, overbought above −20
Neutral
CCI (20)
100.1
Oversold below −100, overbought above 100
Overbought
Rate of change
+49.8%
Change over 10 sessions
Bullish
ATR (14)
$5.20
Typical daily range, 18.3% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for SRZN
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how SRZN did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow SRZN usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for SRZNHow many large options trades hit SRZN, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in SRZN in the last 90 days.
From SEC Form 4 filings by SRZN's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether SRZN is in one of them and how their past SRZN trades turned out.
Surrozen is a biotechnology company based in South San Francisco, California. It develops antibody-based drug candidates that act on the Wnt pathway, a signaling system involved in tissue repair. Its main focus is eye disease, with candidates in development for diabetic macular edema and the wet form of macular degeneration, conditions treated by eye specialists. The company also has a development agreement with Boehringer Ingelheim for a related candidate.